Vectorious
Our story begins with a meeting back in 2011 between the founders, Oren Goldshtein and Dr. Eyal Orion, MD. The two of them identified the existing heart failure management as a clear unmet clinical need and tried to imagine the next stage of implantable hemodynamic monitoring, without limiting themselves with technological and medical constraints. Vectorious Medical Technologies developed the V-LAP, the world`s first in-heart microcomputer - enabling optimal treatment for heart disease patients, increasing their quality of life and life expectancy. At that time, the only way to really understand what was happening in the patient’s heart was to insert a catheter with a pressure sensing tip inside a hospital environment, which proved costly and impractical. V-LAP procedure done in London, and how this first and only micro-computer gets implanted into human hearts, which can help millions around the world.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Monitoring
- Market Focus:
- Globally (various continents)
About Us
Our Story
What if there is a way to harness technology so that we can have the most accurate and specific physiological indication available daily and remotely at home?
Utilizing and weaving together their professional backgrounds, they conceived of the V-LAP to remotely monitor the heart’s left atrial pressure. With this foresight, our team understands the power of bringing digitally generated data from the heart and using AI-based analysis to improve treatment decisions and outcomes for patients suffering from heart failure.
Fast forward to the present day, and Vectorious’ team has successfully implanted in-heart micro computers in multiple countries across Europe and Israel. Our clinical study has been demonstrated huge potential in helping millions of people living with heart failure to take control and manage their disease, keeping them stable, out of hospitals, and living longer, fuller lives.
Vision
Every patient with chronic heart disease, will be remotely monitored by in-body micro-sensors. This would enable a personalized, data driven treatment, at the convenience of the patient's home and would halt the disease’s deterioration.
Mission
We are on a mission of harvesting pressure data from the heart remotely with the world's first in-heart microcomputer.
Based on this data we will be providing valuable insights that will help caregivers make informed decisions to halt heart failure progression.